000 | 03086 a2200901 4500 | ||
---|---|---|---|
005 | 20250516091110.0 | ||
264 | 0 | _c20120727 | |
008 | 201207s 0 0 eng d | ||
022 | _a1460-2156 | ||
024 | 7 |
_a10.1093/brain/aws100 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPetratos, Steven | |
245 | 0 | 0 |
_aLimiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. _h[electronic resource] |
260 |
_bBrain : a journal of neurology _cJun 2012 |
||
300 |
_a1794-818 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _xtherapeutic use |
650 | 0 | 4 |
_aAxons _xmetabolism |
650 | 0 | 4 |
_aCD3 Complex _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aDemyelinating Diseases _xetiology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGPI-Linked Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aGene Expression Regulation _xgenetics |
650 | 0 | 4 |
_aGlycoproteins _xadverse effects |
650 | 0 | 4 |
_aGreen Fluorescent Proteins _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoprecipitation |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Sclerosis _xcomplications |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 |
_aMyelin Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMyelin-Oligodendrocyte Glycoprotein |
650 | 0 | 4 |
_aNerve Degeneration _xetiology |
650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
650 | 0 | 4 |
_aNeuroblastoma _xpathology |
650 | 0 | 4 |
_aNeurofilament Proteins _xmetabolism |
650 | 0 | 4 | _aNogo Receptor 1 |
650 | 0 | 4 |
_aOptic Nerve _xmetabolism |
650 | 0 | 4 |
_aPeptide Fragments _xadverse effects |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
650 | 0 | 4 |
_aRetinal Ganglion Cells _xmetabolism |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSilver Staining |
650 | 0 | 4 |
_aSpinal Cord _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransduction, Genetic |
650 | 0 | 4 |
_aTubulin _xmetabolism |
650 | 0 | 4 |
_atau Proteins _xmetabolism |
700 | 1 | _aOzturk, Ezgi | |
700 | 1 | _aAzari, Michael F | |
700 | 1 | _aKenny, Rachel | |
700 | 1 | _aLee, Jae Young | |
700 | 1 | _aMagee, Kylie A | |
700 | 1 | _aHarvey, Alan R | |
700 | 1 | _aMcDonald, Courtney | |
700 | 1 | _aTaghian, Kasra | |
700 | 1 | _aMoussa, Leon | |
700 | 1 | _aMun Aui, Pei | |
700 | 1 | _aSiatskas, Christopher | |
700 | 1 | _aLitwak, Sara | |
700 | 1 | _aFehlings, Michael G | |
700 | 1 | _aStrittmatter, Stephen M | |
700 | 1 | _aBernard, Claude C A | |
773 | 0 |
_tBrain : a journal of neurology _gvol. 135 _gno. Pt 6 _gp. 1794-818 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/brain/aws100 _zAvailable from publisher's website |
999 |
_c21742275 _d21742275 |